These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 11222470

  • 1. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
    Skudicky D, Bergemann A, Sliwa K, Candy G, Sareli P.
    Circulation; 2001 Feb 27; 103(8):1083-8. PubMed ID: 11222470
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol. Results of a randomised study].
    Latini R.
    Ital Heart J Suppl; 2001 Jun 27; 2(6):692-3. PubMed ID: 11460849
    [No Abstract] [Full Text] [Related]

  • 4. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
    Metra M, Nodari S, Garbellini M, Boldi E, Rosselli F, Milan E, Giubbini R, Dei Cas L.
    Cardiologia; 1997 May 27; 42(5):503-12. PubMed ID: 9289367
    [Abstract] [Full Text] [Related]

  • 5. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
    Metra M, Nardi M, Giubbini R, Dei Cas L.
    J Am Coll Cardiol; 1994 Dec 27; 24(7):1678-87. PubMed ID: 7963115
    [Abstract] [Full Text] [Related]

  • 6. Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Sliwa K, Woodiwiss A, Candy G, Badenhorst D, Libhaber C, Norton G, Skudicky D, Sareli P.
    Am J Cardiol; 2002 Nov 15; 90(10):1118-22. PubMed ID: 12423714
    [Abstract] [Full Text] [Related]

  • 7. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
    Bajcetic M, Kokic Nikolic A, Djukic M, Kosutic J, Mitrovic J, Mijalkovic D, Jovanovic I, Simeunovic S, Spasic MB, Samardzic R.
    Clin Ther; 2008 Apr 15; 30(4):702-14. PubMed ID: 18498919
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
    Di Lenarda A, Sabbadini G, Salvatore L, Sinagra G, Mestroni L, Pinamonti B, Gregori D, Ciani F, Muzzi A, Klugmann S, Camerini F.
    J Am Coll Cardiol; 1999 Jun 15; 33(7):1926-34. PubMed ID: 10362195
    [Abstract] [Full Text] [Related]

  • 9. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA, Gilbert EM, Christian PE, Datz FL, Mealey PC, Volkman K, Olsen SL, Bristow MR.
    Am J Cardiol; 1996 Oct 01; 78(7):779-84. PubMed ID: 8857482
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure.
    Palazzuoli A, Carrera A, Calabria P, Puccetti L, Pastrorelli M, Pasqui AL, Auteri A, Bruni F.
    Am Heart J; 2004 Jan 01; 147(1):E2. PubMed ID: 14691440
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study.
    Patrianakos AP, Parthenakis FI, Mavrakis HE, Diakakis GF, Chlouverakis GI, Vardas PE.
    Am Heart J; 2005 Nov 01; 150(5):985. PubMed ID: 16290981
    [Abstract] [Full Text] [Related]

  • 13. Effects of carvedilol on right ventricular ejection fraction and cytokines levels in patients with systolic heart failure.
    Tatli E, Kurum T, Aktoz M, Buyuklu M.
    Int J Cardiol; 2008 Apr 10; 125(2):273-6. PubMed ID: 18053592
    [Abstract] [Full Text] [Related]

  • 14. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.
    Packer M, Colucci WS, Sackner-Bernstein JD, Liang CS, Goldscher DA, Freeman I, Kukin ML, Kinhal V, Udelson JE, Klapholz M, Gottlieb SS, Pearle D, Cody RJ, Gregory JJ, Kantrowitz NE, LeJemtel TH, Young ST, Lukas MA, Shusterman NH.
    Circulation; 1996 Dec 01; 94(11):2793-9. PubMed ID: 8941104
    [Abstract] [Full Text] [Related]

  • 15. Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial.
    Cice G, Ferrara L, Di Benedetto A, Russo PE, Marinelli G, Pavese F, Iacono A.
    J Am Coll Cardiol; 2001 Feb 01; 37(2):407-11. PubMed ID: 11216954
    [Abstract] [Full Text] [Related]

  • 16. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.
    Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P.
    Lancet; 1998 Apr 11; 351(9109):1091-3. PubMed ID: 9660578
    [Abstract] [Full Text] [Related]

  • 17. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, Libhaber C, Sareli P, Essop R.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1825-30. PubMed ID: 15519014
    [Abstract] [Full Text] [Related]

  • 18. Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms.
    Bahrmann P, Hengst UM, Richartz BM, Figulla HR.
    Eur J Heart Fail; 2004 Mar 01; 6(2):195-201. PubMed ID: 14984727
    [Abstract] [Full Text] [Related]

  • 19. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR.
    J Am Coll Cardiol; 1995 May 01; 25(6):1225-31. PubMed ID: 7722114
    [Abstract] [Full Text] [Related]

  • 20. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
    Huang M, Zhang X, Chen S, Sun Y, Xiao Y, Sun J, Huang M, Chen S, Liu F.
    Pediatr Cardiol; 2013 Mar 01; 34(3):680-5. PubMed ID: 23108482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.